Heart failure in advanced age;Niewydolność serca u pacjentów w wieku podeszłym

Polskie Archiwum Medycyny Wewnetrznej

Volumn 112, Issue SPEC. ISS., 2004, Pages 125-138

  Małecki, Robert ^a   Świtalski, Marek ^b   Małecka, Longina ^c   Imiela, Jacek ^a  

^a Centralny Szpital Kolejowy SPZOZ   (Poland)

^b Wojewodzki Szpital Zespolonego   (Poland)

^c INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Diastolic; Elderly patients; Heart failure; Systolic

Indexed keywords

BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BRAIN NATRIURETIC PEPTIDE; CAPTOPRIL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; EPLERENONE; LISINOPRIL; METOPROLOL; NESIRITIDE; PERINDOPRIL; QUINAPRIL; RAMIPRIL; SPIRONOLACTONE; TRANDOLAPRIL;

AGED; AGING; AWARENESS; BETA ADRENERGIC RECEPTOR BLOCKING; CONFERENCE PAPER; DIASTOLIC BLOOD PRESSURE; ELDERLY CARE; EUROPE; HEART FAILURE; HEART LEFT VENTRICLE; HOSPITALIZATION; HUMAN; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PROGNOSIS; PUBLIC HEALTH; STRUCTURE ACTIVITY RELATION; SYMPTOMATOLOGY; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT CONTRAINDICATION;

EID: 6344284558     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. Lye M., Donnellan C.: Heart disease in the elderly. Heart. 200, 84, 560-566.
2. Pascaul J.: Heart disease in older patients. Practitioner 1998, 242, 577-586.
3. Havranek E.P., Masoudi F.A., Westfall K.A. i wsp.: Spectrum of heart failure in older patients: results from national heart failure project. Am. Heart J. 2002, 143, 412-417.
4. Grajek S.: Zmiany strukturalne w sercu w wieku podeszłym - wybrane zagadnienia.(red.) Grodzicki T., Gryglewska B., Dubiel J.S. Kardiologia u osób w wieku podeszłym. Medical Press Gdańsk 2003.
5. Poole-Wilson P.A.: Changing ideas in the treatment of heart failure an overview. Cardiology. 1987, 74 Suppl 1, 53-57.
6. Mair F.S., Crowley T.S., Bundred P.E.: Prevalence, aetiology and management of heart failure in general practice. Br. J. Gen. Pract., 1996, 46, 77-79.
7. Lye M.: Access to advances in cardiology. Lancet, 1997, 350, 1162.
8. Ahmed A.: Management of diastolic heart failure in older adults. BMJ 2004, 328, 1114.
9. Vasan R.S., Levy D.: Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000, 101, 2118-2121.
10. Ogawa T., Spina R.J., Martin III W.J. i wsp.: Effects of aging, sex and physical training on cardiovascular responses to exercise. Circulation 1992, 86, 494-503.
11. Raymond I., Pedersen F., Steensgaard-Hansen F. i wsp.: Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen. Heart 2003, 89, 1422-1429.
12. Clarkson P.B.M., Wheeldon N.M., Macleod C. i wsp.: Effects of angiotensin-II and aldosterone on diastolic function in-vivo in normal man. Clin. Sci. 1994, 87, 397-401.
13. Luchi R.J., Taffet G.E., Teasdale T.A.: Congestive heart failure in the elderly. J. Am. Geriatr. Soc., 1991, 39, 810-825.
14. European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure. Eur. Heart. J., 1998, 19, 990-1003
15. Zile M.R., Baicu C.F., Gaasch W.H.: Diastolic heart failure - Abnormalities in active relaxation and passive stiffness of the left ventricle. N. Engl. J. Med., 2004, 350, 1953.
16. Adams V., Jiang H., Yu J. i wsp.: Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. J. Am. Coll. Cardiol., 1999, 33, 959-965.
17. McMurray J.J.V., Stewart S.: Nurse led, multidisciplinary intervention in chronic heart failure. Heart 1998, 80, 430.
18. Pitt B., Zannad F., Remme W.J. i wsp.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N. Engl. J. Med., 1999, 341, 709-717.
19. The Captopril-Digoxin Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J. Am. Coll. Cardiol., 1983, 2, 755-763.
20. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N. Engl. J. Med., 1991, 325, 293-302.
21. Schwartz D., Kornowski R., Schwartz I.F. i wsp. Prediction of renal impairment in elderly patients with congestive heart failure treated with captopril. Cardiovasc Drugs Ther., 1996, 10, 75-79.
22. Pilote L., Abrahamowicz M., Rodrigues E. i wsp. Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after Acute Myocardial Infarction: A Class Effect? Ann. Intern. Med., 2004, 141, 102-112.
23. Baker D.W., Konstam M.A., Bottorff M. i wsp.: Management of heart failure. I. Pharmacologic treatment. JAMA, 1994, 272, 1361.
24. Pfeffer U.A., Swedberg K., Granger C.B. i wsp. CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet, 2003, 362, 759-766.
25. Pitt B., Segal R., Martinez F.A. i wsp. Randomised trial of losartan versus captopril in patients over 65 with heart failure (evaluation of losartan in the elderly study, ELITE). Lancet, 1997, 349, 747-752
26. Pitt B., Poole-Wilson P.A., Segal R. i wsp.: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial - the losartan heart failure survival study ELITE II. Lancet, 2000, 355, 1582.
27. Dahlof B., Devereux R.B., Kjeldsen S.E. i wsp.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomized trial against atenolol. Lancet, 2002, 359, 995-1003.
28. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med., 1997, 336(8), 525-533.
29. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med., 1997, 336, 525-533.
30. Foody J.M., Farrell M.H., Krumholz H.M.: Beta-blocker therapy in heart failure: scientific review. JAMA. 2002, 287, 883-889.
31. Gibbs C.R., Davies M.K., Lip G.Y.H.: ABC of heart failure - Management: digoxin and other inotropes, beta blockers, and antiarrhythmic and antithrombotic treatment. BMJ, 2000, 320, 495.
32. Krum H., Roecker E.B., Mohacsi P. i wsp:. Effects of initiating carvedilol in patients with severe chronic heart failure. Results from the COPERNICUS Study. JAMA, 2003, 289, 712-718.
33. Gottlieb S.S., Fisher M.L., Kjekshus J. i wsp.: Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Circulation, 2002, 105, 1182-1188.
34. Ko D., Hebert P.R., Coffey C.S.: i wsp.: Adverse Effects of β-Blocker Therapy for Patients With Heart Failure: A Quantitative Overview of Randomized Trials. Arch. Intern. Med., 2004, 164, 1389-1394.
35. Kitzman D.W., Little W.C., Brubaker P.H. i wsp.: Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA, 2002, 288, 2144-2150.
36. Hunt S.A., Baker D.W., Chin M.H. i wsp. ACC//AHA guidelines for the evaluation and management of chronic heart failure in the adult. J. Am. Coll. Cardiol., 2001, 38, 2101-2113.
37. Remme W.J., Swedberg K.: Guidelines for the diagnosis and treatment of chronic heart failure. Eur. Heart J. 2001, 22, 1527-1560
38. Gheorghiade M., Adams K.F., Colucci K.S.: Digoxin in management of cardiovascular disorders. Circulation, 2004, 109, 2959
39. Cleland J.G.F., Tendera M., Adamus J. i wsp.: Perindopril for elderly people with chronic heart failure: the PEP-CHF study. Eur. J. Heart. Failure., 1999, 1, 211.
40. Arrighi J.A., Dilsizian V., Perronefilardi P. i wsp.: Improvement of the age-related impairment in left-ventricular diastolic filling with verapamil in the normal human heart. Circulation 1994, 90, 213-219.
41. Manning W.J., Shannon R.P., Santinga J.A. i wsp.: Reversal of changes in left ventricular diastolic filling associated with normal ageing using diltiazem. Am. J. Cardiol., 1991, 67, 894.
42. Bergström A., Andersson B., Edner M. i wsp. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur. J. Heart Fail., 2004, 6, 456-461.
43. Tandon P., McAlister F.A., Tsuyuki R.T. i wsp.: The Use of β-Blockers in a Tertiary Care Heart Failure Clinic. Dosing, Tolerance, and Outcomes. Arch. Intern. Med., 2004, 164, 769-774.
44. Krumholz H.M., Radford M.J., Wang Y. i wsp.: National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA, 1998, 280, 623.
45. Page J., Henry D.: Consumption of NSAIDs and the Development of Congestive Heart Failure in Elderly Patients. An Underrecognized Public Health Problem. Arch. Intern. Med., 2000, 160, 777-784.
46. Hare J.M.: Cardiac-resynchronization therapy for heart failure. N. Engl. J. Med., 2002, 346, 1902-1905.
47. Abraham W.T., Fisher W.G., Smith A.L. i wsp.: Cardiac resynchronization in chronic heart failure. N. Engl. J. Med., 2002, 346, 1845-1853.
48. Bradley D.J., Bradley E.A., Baughman K.L. i wsp.: Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA, 2003, 289, 730-740.
49. Shen W.K., Hammill S.C., Hayes D.L. i wsp.: Long-term survival after pacemaker implantation for heart block in patients > 65 years. Am. J. Cardiol., 1994, 74, 560-564.
50. Havranek E.P., Abrams F., Stevens E., Parker K.: Determinants of mortality in elderly patients with heart failure. The role of angiotensin-converting enzyme inhibitors Arch. Intern. Med., 1998, 158, 2024-2028.
51. Mendelson G., Aronow W.S.: Underutilization of angiotensin-converting enzyme inhibitors in older patients with Q-wave anterior myocardial infarction in an academic hospital-based geriatrics practice. J. Am. Geriatr. Soc., 1998, 46, 751.
52. Lemaitre R.N., Furberg C.D., Newman A.B. i wsp. Time trends in the use of cholesterol-lowering agents in older adults: the Cardiovascular Health Study. Arch. Intern. Med., 1998, 158, 1761.
53. Aronow W.S.: Underutilization of aspirin in older patients with prior myocardial infarction at the time of admission to a nursing home. J. Am. Geriatr. Soc., 1998, 46, 615.
54. Brass L.M., Krumholz H.M., Scinto J.D., Mathur D., Radford M.: Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation. Arch. Intern. Med., 1998, 158, 2093-2100.
55. Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet. 2002, 360(9346), 1631.
56. Rywik T.M., Rywik S.L., Korewicki J. i wsp. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns. Int. J. Cardiol., 2004, 95, 177-184.